Myelin Oligodendrocyte Glycoprotein-Immunoglobulin G in the CSF: Clinical Implication of Testing and Association With Disability

This study provides Class II evidence that the presence of CSF MOG-IgG can improve the diagnosis of MOGAD in the absence of an MS phenotype, and intrathecal synthesis of MOG-IgG was associated with increased disability.

http://nn.neurology.org/cgi/content/short/9/1/e1095?rss=1

Source: Neurology Neuroimmunology and Neuroinflammation - October 28, 2021 Category: Neurology Authors: Kwon, Y. N., Kim, B., Kim, J.-S., Mo, H., Choi, K., Oh, S.-i., Kim, J.-E., Nam, T.-S., Sohn, E. H., Heo, S. H., Kim, S. B., Park, K.-C., Yoon, S. S., Oh, J., Baek, S.-H., Kim, B.-J., Park, K. S., Sung, J.-J., Jung, J. H., Kim, S.-J., Park, S.-H., Waters, Tags: Class II, All Demyelinating disease (CNS) Article Source Type: research